About: Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 2008

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 2008 (uk) im Mai 2008 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 2008 (ast) scientific article published on 01 May 2008 (en)
publication date	wds:Q60665153-F394BAC3-1617-4AC6-9501-A64A7ACAF287
publication date	2008-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q60665153-2F99ADC5-EC60-44A2-B99B-4F305E3245F2
language of work or name	English
author name string	wds:Q60665153-0B518CC0-ECBD-4CAB-B28B-759843B9A9F1 wds:Q60665153-2B8EDBC1-C001-478B-8062-8CD91A5293B6 wds:Q60665153-5DA3A362-EB12-4155-87B1-973B46034394 wds:Q60665153-C1A89F74-45F4-462A-95A6-37C0E2F4BFF3 wds:Q60665153-E8E059FD-3F9A-4EF5-839C-5C545DEA2EFD wds:Q60665153-F785F52B-9B98-4503-80D3-D36975396475
author name string	Gerold Schuler Kris Thielemans Pierre G Coulie Aline Van Pel Danièle Godelaine Thierry Connerotte
rdfs:label	Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities (en) Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities (nl)
skos:prefLabel	Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities (en) Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities (nl)
name	Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities (en) Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities (nl)
author	wds:Q60665153-3CBFA40C-73F7-4B93-AC5F-026F3BD4226C wds:Q60665153-9417545F-CF81-4875-8C72-E58A38FA90BE wds:Q60665153-B0F529FB-CD8A-4442-9F83-2C2C82AABCFB
author	Sophie Lucas Eric Tartour Beatrice Schuler-Thurner
title	wds:Q60665153-8739C448-BF77-4DF4-B439-ACE7714A6549
title	Functions of Anti-MAGE T-cells induced in melanoma patients under different vaccination modalities (en)
page(s)	wds:Q60665153-1007D02E-441D-42A4-A6FD-88CBBC4A747B
page(s)	3931-3940
instance of	wds:Q60665153-63A3C922-B58F-4B2A-9C93-C9192760493A
instance of	scholarly article
PubMed ID	wds:Q60665153-E8D595DD-89D7-452E-B74F-913368BBEB08
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18483279
PubMed ID	18483279
published in	wds:Q60665153-73AADE3A-6070-413E-954A-A8B2F0247E99
published in	Cancer Research
issue	wds:Q60665153-1E04AE02-3956-4413-BCB3-8322888FB31D
volume	wds:Q60665153-59E4E67B-C5C1-4ACA-B182-3C71ABCAE8BB
issue	10
volume	68
DOI	wds:Q60665153-6F26D8B5-63D8-4E85-9C4E-01CBDC68BA6B
DOI	http://dx.doi.org/10.1158/0008-5472.CAN-07-5898
DOI	10.1158/0008-5472.CAN-07-5898
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q60665153
is cites work of	Different affinity windows for virus and cancer-specific T-cell receptors: implications for therapeutic strategies Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma. Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells Similar inflammatory DC maturation signatures induced by TNF or Trypanosoma brucei antigens instruct default Th2-cell responses Cancer testis antigen and immunotherapy Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium Dendritic cell vaccination and immune monitoring. Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans Dendritic cells in cancer immunotherapy HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor Driving gene-engineered T cell immunotherapy of cancer Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients. GK-1 improves the immune response induced by bone marrow dendritic cells loaded with MAGE-AX in mice with melanoma. Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs MAGE-A Antigens and Cancer Immunotherapy Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes CARs and other T cell therapies for MM: The clinical experience Advances in cellular therapy for the treatment of thyroid cancer Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014. Antigen-specificity and DTIC before peptide-vaccination differently shape immune-checkpoint expression pattern, anti-tumor functionality and TCR repertoire in melanoma patients
is cites work of	wds:Q34271609-98E18001-3535-456B-BEEB-705DC38A2802 wds:Q39838716-CE8007D2-7B5C-4623-AE32-1D554E1ECEB2 wds:Q34297618-D68736CE-D068-47E1-AE11-BD633EE810E4 wds:Q90207660-FECA5CA7-3208-451E-A9E3-D9E4A5F14B5E wds:Q38912232-14FBDAB9-BB25-4C7E-A5B8-34C45E9F6617 wds:Q91751487-EA77CE93-4DBA-48EB-B6EC-25D1E5668FA3 wds:Q38364462-DD4FA96C-5031-44DA-AEF9-6523A7561075 wds:Q36510860-AB2DBEB8-C8AB-4987-A6A3-020DC9E18C8D wds:Q37685379-320717FF-E39A-4CC6-B575-78668E082388 wds:Q37095348-147450FC-184B-47B3-8F17-41C705CCB197 wds:Q37212802-2D041EF3-E33F-423B-A786-B202E3E63E2E wds:Q39113639-00B2B426-C3D2-451E-97C5-DEBE8C2E64A9 wds:Q30439109-3C39FDF7-678A-4858-BD7F-62DB4431C2DB wds:Q36637039-52AB8819-7CBF-4E21-A2BB-4035B28FBFB7 wds:Q38777742-96F4F221-A2A9-49A7-84EA-52F712949A29 wds:Q41901253-8AD14EE0-33B1-4F3F-964A-93CBF804B827 wds:Q85052740-6916BE23-9E9C-4C8D-A643-277723FEE107 wds:Q58662838-BF312863-B99E-45B2-8F64-AFB42BBE6E4E wds:Q33566336-E19503E6-442A-4A53-A069-9901DE9C56DE wds:Q89128650-6CBC8030-6F8B-42FF-99E4-2879294201C6 wds:Q30846001-6E181251-334F-4017-836A-9F6B6148C5BB wds:Q37776660-B16F69FD-1C64-4D30-A34D-269DCAC443AC wds:Q43147493-4CBAB442-004B-48F4-A83F-780582D06500

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software